SPY316.70-0.35 -0.11%
DIA261.02-1.98 -0.75%
IXIC10,479.70+46.05 0.44%

SunTrust Robinson Humphrey Maintains Buy on Vertex Pharmaceuticals, Raises Price Target to $330

SunTrust Robinson Humphrey maintains Vertex Pharmaceuticals (NASDAQ:VRTX) with a Buy and raises the price target from $285 to $330.

Benzinga · -
SunTrust Robinson Humphrey maintains Vertex Pharmaceuticals (NASDAQ: VRTX) with a Buy and raises the price target from $285 to $330.